These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7669716)

  • 1. Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.
    Pia A; Berruti A; Terzolo M; Paccotti P; Letizia C; Dogliotti L; Angeli A
    Ann Oncol; 1995 May; 6(5):509-10. PubMed ID: 7669716
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
    Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
    Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
    Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
    Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.
    Berruti A; Terzolo M; Paccotti P; Veglio F; Pia A; Dogliotti L; Angeli A
    Tumori; 1992 Oct; 78(5):345-8. PubMed ID: 1494808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.
    Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L
    Endocr Relat Cancer; 2005 Sep; 12(3):657-66. PubMed ID: 16172198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy in advanced adrenocortical carcinoma.
    Fassnacht M; Terzolo M; Allolio B; Baudin E; Haak H; Berruti A; Welin S; Schade-Brittinger C; Lacroix A; Jarzab B; Sorbye H; Torpy DJ; Stepan V; Schteingart DE; Arlt W; Kroiss M; Leboulleux S; Sperone P; Sundin A; Hermsen I; Hahner S; Willenberg HS; Tabarin A; Quinkler M; de la Fouchardière C; Schlumberger M; Mantero F; Weismann D; Beuschlein F; Gelderblom H; Wilmink H; Sender M; Edgerly M; Kenn W; Fojo T; Müller HH; Skogseid B;
    N Engl J Med; 2012 Jun; 366(23):2189-97. PubMed ID: 22551107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
    Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
    Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma.
    Bonacci R; Gigliotti A; Baudin E; Wion-Barbot N; Emy P; Bonnay M; Cailleux AF; Nakib I; Schlumberger M;
    Br J Cancer; 1998 Aug; 78(4):546-9. PubMed ID: 9716042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.
    Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M
    Endocr Relat Cancer; 2017 Jul; 24(7):319-327. PubMed ID: 28432084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16).
    Johnson DH; Greco FA
    Cancer; 1986 Nov; 58(10):2198-202. PubMed ID: 3756767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.
    Hantel C; Jung S; Mussack T; Reincke M; Beuschlein F
    Endocr Relat Cancer; 2014 Jun; 21(3):383-94. PubMed ID: 24532475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma.
    Jung S; Nagy Z; Fassnacht M; Zambetti G; Weiss M; Reincke M; Igaz P; Beuschlein F; Hantel C
    Endocr Relat Cancer; 2016 Oct; 23(10):825-37. PubMed ID: 27550961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adrenocortical carcinoma and its treatment].
    Tupikowski W; Bednarek-Tupikowska G; Florczak A
    Postepy Hig Med Dosw (Online); 2004 Feb; 58():27-36. PubMed ID: 15069374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical carcinoma.
    van Ditzhuijsen CI; van de Weijer R; Haak HR
    Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment for adrenocortical carcinoma].
    Iihara M; Obara T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):342-5. PubMed ID: 15045937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic chemotherapy for adrenocortical carcinoma.
    Dogliotti L; Berruti A; Pia A; Paccotti P; Alì A; Angeli A
    Minerva Endocrinol; 1995 Mar; 20(1):105-9. PubMed ID: 7544429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal cortical carcinoma: the role of adjuvant postoperative chemotherapy.
    Burgess MA
    Minerva Endocrinol; 1995 Mar; 20(1):101-4. PubMed ID: 7651278
    [No Abstract]   [Full Text] [Related]  

  • 19. Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma.
    Cosentini D; Turla A; Carminati O; Grisanti S; Ferrari VD; Laganà M; Rosti G; Sigala S; Berruti A
    Front Endocrinol (Lausanne); 2021; 12():674039. PubMed ID: 33967965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission].
    Ueda S; Nakane K; Namiki S; Takeuchi Y; Kawase M; Takeuchi S; Kawase K; Nakai C; Kato D; Takai M; Iinuma K; Tsuchiya T; Miyazaki T; Koie T
    Hinyokika Kiyo; 2022 May; 68(5):139-143. PubMed ID: 35748231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.